Form 4: Agilysys Director Executes Stock Option Exercise
Statement of Changes in Beneficial Ownership
Director Donald A. Colvin acquired 973 shares of Agilysys common stock through the exercise of restricted stock units.
Summary
- Director Donald A. Colvin exercised 973 restricted stock units (RSUs) on May 22, 2026.
- The transaction resulted in the acquisition of 973 shares of Agilysys, Inc. (AGYS) common stock.
- Following the transaction, the director holds a total of 25,565 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, representing standard equity compensation vesting for a company director.
Positives
- Director maintains a significant equity stake of 25,565 shares, aligning interests with shareholders.
Negatives
- None identified.
Risks
- None identified.
Future Outlook
No forward-looking guidance provided in this filing.
Industry Context
StockSavvy.ai notes that routine RSU exercises by directors are standard corporate governance practices and generally do not signal a change in strategic direction or market sentiment.
Comparison to Industry Standards
- The transaction is consistent with standard executive compensation and equity vesting schedules observed in the software and hospitality technology sectors.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine equity compensation event.
Key Dates
| Date | Description |
|---|---|
| 05/22/2026 | Date of the RSU exercise and acquisition of common stock. |
| 05/27/2026 | Date the Form 4 filing was signed and submitted. |
Keywords
Agilysys, AGYS, Insider Trading, Form 4, Director, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.